A phase 3 trial involving nearly 25,000 older adults across 17 countries found that a single dose of the RSVPreF3 OA vaccine ...

A single dose of the RSVPreF3 OA vaccine offers strong protection against RSV-related lower respiratory tract disease in ...

Respiratory syncytial virus (RSV) is a negative-stranded ... are the primary targets of the humoral response. RSV is a major seasonal viral respiratory pathogen in infants, young children ...

Under direction of Health Secretary Robert F. Kennedy Jr., the CDC is considering changes to its recommendations on vaccines ...

For respiratory conditions like influenza and Respiratory Syncytial Virus (RSV), mRNA vaccines ... across a wide disease spectrum- from seasonal viruses to chronic, life-threatening, and ...

“These are respiratory illnesses that can ... “Influenza is a particularly challenging virus as it mutates in a seasonal pattern. The rate of change to the mutations can impact how quickly ...

Populations of animals and plants separated by even thousands of miles can rise and fall together driven by ecological ...

As spring temperatures rise along with pollen counts in Georgia, the state is seeing a decline in winter respiratory ...

Nirsevimab showed 74.5% efficacy against medically attended lower respiratory tract infections caused by RSV in healthy infants in the trial compared to placebo.

Nasal Spray H5N1 Avian Influenza Vaccine Developed Apr. 8, 2025 — Scientists have pioneered an influenza virus vector-based ... adults who were exposed to seasonal flu viruses that circulated ...